Treat

Admedus Immunotherapies

Learn More

Repair

Admedus Tissue Engineering

Learn More

Deliver

Admedus Medical Products

Learn More

Welcome to Admedus

We are a diversified healthcare group that is developing, investing in and delivering a range of exciting new technologies and leading edge medical devices that have the potential to make a real difference to the outcomes and quality of life of patients around the globe.

Learn More

ambIT® Continuous Infusion Pump

Enhance Patients' Comfort and Mobility

Read More

Browse Products

Our range of medical products and devices combines quality and value with the very latest technology

News & Media

< >

Admedus next generation vaccine technology targets HPV

2016 is looking to be an important year for Admedus as our immunotherapy programs continue to progress well. Working with Professor Ian Frazer and his team, we are developing therapeutic vaccines to target human papillomavirus (HPV) and herpes simplex virus 2 (HSV-2). These vaccines address significant diseases with a huge unmet medical need and if successful, […]

February 12th 2016

Find out more

Open Letter From Mr Wayne Paterson To Shareholders

Dear Shareholders and friends of Admedus, I would like to take the opportunity to update you on current events and what you can expect from the team moving forward.

February 10th 2016

Find out more

Admedus inks exclusive distro deal with Coroneo

Admedus (ASX:AHZ) has inked an exclusive distribution agreement with Coroneo to sell its extra aortic annuloplasty ring and other heart valve surgery instruments in Germany and the U.K.

January 27th 2016

Find out more

CardioCel bio-scaffold launched and sold in Malaysia

CardioCel has now been launched in Malaysia and the Company has achieved its first sales in the country.

November 4th 2015

Find out more

Admedus HSV-2 vaccine set for key value inflection point

In an interview with leading online biotech site, BioTuesdays, Chief Operating Officer Julian Chick discusses Admedus’ anticipated interim results from a Phase 2 trial of its therapeutic vaccine for the treatment of herpes simplex virus-2 (HSV-2).

September 22nd 2015

Find out more

Upcoming Events

16th Annual International Symposium on Congenital Heart Disease

February 13th 2016 See event details
19th Annual Update on Pediatric and Congenital Cardiovascular Disease

February 24th 2016 See event details
Cleveland Clinic Valve Disease and Diastology Summit

March 4th 2016 See event details
Heart Valve Society Scientific Meeting

March 17th 2016 See event details